LIDGARD GRAHAM PETER 3
3 · EXACT SCIENCES CORP · Filed Jan 11, 2021
Insider Transaction Report
Form 3
LIDGARD GRAHAM PETER
SVP, Chief Scientific Officer
Holdings
- 12,725(indirect: By 401(k))
Common Stock
Stock Option (right to buy)
Exercise: $92.62→ Common Stock (8,090 underlying)Restricted Stock Units
→ Common Stock (15,888 underlying)- 33,755
Common Stock
- 4,673(indirect: By Trust)
Common Stock
Restricted Stock Units
→ Common Stock (10,050 underlying)Stock Option (right to buy)
Exercise: $21.68→ Common Stock (20,250 underlying)Restricted Stock Units
→ Common Stock (11,575 underlying)Restricted Stock Units
→ Common Stock (9,789 underlying)Stock Option (right to buy)
Exercise: $44.37→ Common Stock (8,350 underlying)Stock Option (right to buy)
Exercise: $98.18→ Common Stock (12,875 underlying)
Footnotes (9)
- [F1]Represents a restricted stock unit award that vests in full on February 23, 2021.
- [F2]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F3]Represents a restricted stock unit award that vests in two equal annual installments beginning on February 27, 2021.
- [F4]Represents a restricted stock unit award that vests in three equal annual installments beginning on February 26, 2021.
- [F5]Represents a restricted stock unit award that vests in four equal annual installments beginning on February 14, 2021.
- [F6]These options vest and become exercisable in full on February 23, 2021.
- [F7]These options vest and become exercisable in two equal annual installments beginning on February 27, 2021.
- [F8]These options vest and become exercisable in three equal annual installments beginning on February 26, 2021.
- [F9]These options vest and become exercisable in four equal annual installments beginning on February 14, 2021.